Security key
29337E102
Enliven Therapeutics, Inc. - COMMON STOCK (ELVN)
CUSIP: 29337E102
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 33,557,749
- Total 13F value
- $734,910,999
- Share change
- +33,557,749
- Put/Call ratio
- 0.14%
- SEC-reported price per share
- $21.90
- Number of holders
- 44
- Value change
- +$734,911,000
- Number of buys
- 44
- Shares outstanding
- 71,423,603
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
44
Top holders
10
ELVN full security history
Ownership snapshot
Full 13F holder table
Enliven Therapeutics, Inc. SEC filings
Enliven Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ELVN - Enliven Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
David P. Bonita
Disclosed value leader
David P. Bonita
Comparable rows
0/15
Latest evidence
23 Feb 2023
3/4/5
Highest disclosed value: $63,552,894
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
David P. Bonita has the largest disclosed position value at $63.55M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens David P. Bonita's linked filing trail.
Disclosed position value
Top 5
David P. Bonita
$63.55M
New Enterprise Associates 14, L.P.
$39.52M
RA CAPITAL MANAGEMENT, L.P.
$32.12M
Braden M. Leonard
$30.24M
Commodore Capital LP
$21.93M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| David P. Bonita |
3/4/5
Director, 10%+ Owner
|
—
mixed-class rows
|
$63,552,894
4,207,568 shares
mixed-class rows
|
— | 02 Jun 2022 |
| New Enterprise Associates 14, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$39,518,242
2,611,050 shares
|
— | 05 Apr 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
Former 10% owner
|
—
class O/S missing
|
$32,123,508
2,122,465 shares
|
— | 23 Feb 2023 |
| Braden M. Leonard |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$30,236,309
1,997,774 shares
|
— | 03 Jan 2023 |
| Commodore Capital LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$21,925,166
1,448,640 shares
|
— | 23 Feb 2023 |
| Andrew J. Schwab |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
—
27,567 shares
|
— | 23 Feb 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
44
Shares
33,557,749
Rows available
44
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
44
Q1 2023 holders
44
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|